ERICA QUIGLEY: Open Payments
NPI 1952935082 · TAMA, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,516 in 104 payments from 15 companies in 2025. Trend: 2023 $952 · 2024 $1,886 · 2025 $1,516
Food & beverage: $1,516
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $333 |
| PFIZER INC. | 29 | $256 |
| AstraZeneca Pharmaceuticals LP | 7 | $158 |
| Amgen Inc. | 15 | $156 |
| Phathom Pharmaceuticals, Inc. | 5 | $116 |
| Novo Nordisk Inc | 6 | $109 |
| Lilly USA, LLC | 5 | $81 |
| Insulet Corporation | 4 | $69 |
| Teva Pharmaceuticals USA, Inc. | 3 | $58 |
| Axsome Therapeutics, Inc. | 3 | $57 |
Products named: VRAYLAR, OTEZLA, VOQUEZNA, NURTEC ODT, QULIPTA, Omnipod, AUSTEDO XR, AIRSUPRA.
Industry payments across IA — which companies pay providers there.
